Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma

[1]  The Icgctcga Pan-Cancer Analysis of Whole Genomes Consortium.  Pan-cancer analysis of whole genomes , 2020 .

[2]  A. Borczuk,et al.  Genomic Underpinnings of Tumor Behavior in in situ and Early Lung Adenocarcinoma. , 2019, American journal of respiratory and critical care medicine.

[3]  Joshua D. Campbell,et al.  Genomic and immune profiling of pre-invasive lung adenocarcinoma , 2019, Nature Communications.

[4]  Kenji Suzuki,et al.  High-Risk Factors for Recurrence of Stage I Lung Adenocarcinoma: Follow-up Data from JCOG0201. , 2019, The Annals of thoracic surgery.

[5]  Yi-long Wu,et al.  Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early-Invasive Lung Adenocarcinoma. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  K. Ashizawa,et al.  Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma , 2019, Nature Communications.

[7]  C. Swanton,et al.  Resolving genetic heterogeneity in cancer , 2019, Nature Reviews Genetics.

[8]  Xue Wu,et al.  The spatiotemporal evolution of early-stage non-small-cell lung cancer. , 2019, Journal of Clinical Oncology.

[9]  Ran Nathan,et al.  Stochastic simulations reveal few green wave surfing populations among spring migrating herbivorous waterfowl , 2019, Nature Communications.

[10]  E. Miyaoka,et al.  Demographics, Safety and Quality, and Prognostic Information in Both the Seventh and Eighth Editions of the TNM Classification in 18,973 Surgical Cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010 , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[11]  P. Campbell,et al.  Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions , 2019, Nature Medicine.

[12]  M. Kunitski,et al.  Double-slit photoelectron interference in strong-field ionization of the neon dimer , 2018, Nature Communications.

[13]  W. Travis,et al.  Implications of the Eighth Edition of the TNM Proposal: Invasive Versus Total Tumor Size for the T Descriptor in Pathologic Stage I‐IIA Lung Adenocarcinoma , 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[14]  Yassen Assenov,et al.  Maftools: efficient and comprehensive analysis of somatic variants in cancer , 2018, Genome research.

[15]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[16]  M. Stratton,et al.  Universal Patterns of Selection in Cancer and Somatic Tissues , 2018, Cell.

[17]  Hongbing Shen,et al.  Whole-genome sequencing reveals genomic signatures associated with the inflammatory microenvironments in Chinese NSCLC patients , 2018, Nature Communications.

[18]  Steven J. M. Jones,et al.  Oncogenic Signaling Pathways in The Cancer Genome Atlas. , 2018, Cell.

[19]  Chuang Tan,et al.  Universal Patterns of Selection in Cancer and Somatic Tissues , 2018, Cell.

[20]  P. A. Futreal,et al.  Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma. , 2017, Cancer research.

[21]  F. Hirsch,et al.  Comprehensive Analysis of EGFR‐Mutant Abundance and Its Effect on Efficacy of EGFR TKIs in Advanced NSCLC with EGFR Mutations , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[22]  Nancy R. Zhang,et al.  BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers , 2017, Nature Communications.

[23]  K. Yamaguchi,et al.  Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors , 2017, Scientific Reports.

[24]  Krishnendu Chatterjee,et al.  Reconstructing metastatic seeding patterns of human cancers , 2017, Nature Communications.

[25]  Michael Lynch,et al.  Genetic drift, selection and the evolution of the mutation rate , 2016, Nature Reviews Genetics.

[26]  Jun S. Liu,et al.  Comprehensive analyses of tumor immunity: implications for cancer immunotherapy , 2016, Genome Biology.

[27]  Siân Jones,et al.  Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA , 2015, Nature Communications.

[28]  Harold Varmus,et al.  Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma , 2015, eLife.

[29]  T. Chan,et al.  Therapeutic targeting of tumor suppressor genes , 2015, Cancer.

[30]  Z. Szallasi,et al.  Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  Steven J. M. Jones,et al.  Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.

[32]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[33]  Takashi Hirai,et al.  Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters. , 2014, The Journal of thoracic and cardiovascular surgery.

[34]  L. Sequist,et al.  The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers. , 2013, The Annals of thoracic surgery.

[35]  D. Aberle,et al.  Results of initial low-dose computed tomographic screening for lung cancer. , 2013, The New England journal of medicine.

[36]  E. Mroz,et al.  MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma. , 2013, Oral oncology.

[37]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[38]  Tatiana Popova,et al.  Supplementary Methods , 2012, Acta Neuropsychiatrica.

[39]  K. Matsuo,et al.  Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  Masahiro Tsuboi,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[41]  Liu Yan-hui,et al.  Interpretation of Pathological Perspective——International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011 .

[42]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[43]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[44]  Takayuki Kosaka,et al.  Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung Adenocarcinoma , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[45]  G. Lorusso,et al.  The tumor microenvironment and its contribution to tumor evolution toward metastasis , 2008, Histochemistry and Cell Biology.

[46]  V. Seshan,et al.  Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.